Absci to participate in the svb securities cyberx: big data, a.i. & machine learning in healthcare event

Vancouver, wash. and new york, july 21, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming svb securities cyberx: big data, a.i. & machine learning in healthcare event.
ABSI Ratings Summary
ABSI Quant Ranking